ASCML
BMY icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Bristol-Myers Squibb BMY Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Sell
1,803
-112
-6% -$6.43K 0.09% 116
2026
Q1 		$116K Sell
1,915
-120
-6% -$7K 0.11% 100
2025
Q4 		$110K Buy
+2,035
New +$97.9K 0.11% 104

Other funds holding BMY

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's BMY Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC reduced its Bristol-Myers Squibb (BMY) stake by 5.8% in Q2 2026, selling an estimated $6.43K and leaving 1,803 shares worth $104K. The position accounts for 0.09% of the portfolio, ranked #116.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $116K in Q1 2026. 1,490 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 1,803 shares of Bristol-Myers Squibb worth $104K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC sold 112 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.43K.
  • Bristol-Myers Squibb made up 0.09% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #116 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC's Bristol-Myers Squibb position peaked at $116K in Q1 2026.
  • 1,490 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.